Telehealth and B2B pharmacy fulfillment from Truepill
The company works with health plans, pharmaceutical manufacturers and consumer health brands to build “direct-to-patient experiences”. With a US-wide pharmacy fulfillment and delivery service and a network of telehealth practitioners, the company’s API allows organisations such as GoodRx, TherapeuticsMD and Nurx to expand their offering to patients.
Truepill says it has the capacity to deliver 100,000 prescriptions per day, and that its telehealth practitioners diagnose and prescribe across 50 states.
Since its foundation in 2016, the company has raised some across five funding rounds. Its latest Series B round, announced yesterday, saw the company raise from investors Trusted Insight, Sound Ventures, Optum Ventures and Initialized Capital.
In , Umar Afridi, Truepill Co-founder and CEO, said: “The healthcare industry is facing the most rapid period of change in our lifetime. From consumer healthcare startups to established industry leaders, everyone has been forced to rethink patient care and redesign their business around access and convenience. While COVID-19 has expedited this reality for many companies, Truepill has been building with a patient-first perspective from day one. We’ve created an end-to-end solution that enables our partners to deliver truly accessible and streamlined patient care.”
The company said it would use the investment to serve increasing demand, as well as expand its existing product offerings.
We are working with our partners to deliver the most innovative healthcare experiences for patients," said Sid Viswanathan, Truepill Co-founder and President. "We are excited to see our API-connected infrastructure being leveraged across the entire healthcare ecosystem. We see a future where over 80% of healthcare visits will be performed using telehealth or a digital experience, and we are positioning Truepill to be the platform building that future."